APA-Zitierstil (7. Ausg.)

Worst, T., Weis, C. T., & Erben, P. (2018). CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making. Scientific reports, 8, . https://doi.org/10.1038/s41598-018-32569-x

Chicago-Zitierstil (17. Ausg.)

Worst, Thomas, Cleo-Aron Thias Weis, und Philipp Erben. "CDKN2A as Transcriptomic Marker for Muscle-invasive Bladder Cancer Risk Stratification and Therapy Decision-making." Scientific Reports 8 (2018). https://doi.org/10.1038/s41598-018-32569-x.

MLA-Zitierstil (9. Ausg.)

Worst, Thomas, et al. "CDKN2A as Transcriptomic Marker for Muscle-invasive Bladder Cancer Risk Stratification and Therapy Decision-making." Scientific Reports, vol. 8, 2018, https://doi.org/10.1038/s41598-018-32569-x.